Tamilnadu Arasu Pokkuvarathu Kazhaga Ooivupettra Poriyalargal Mattrum Kanganippalargal Nala Sangam v. K.Phanindra Reddy, Ias
IN THE HIGH COURT OF JUDICATURE AT MADRAS
DATED : 27.11.2024
CORAM
THE HONOURABLE MS.JUSTICE R.N.MANJULA Tamilnadu Arasu Pokkuvarathu Kazhaga Ooivupettra Poriyalargal Mattrum Kanganippalargal Nala Sangam Rep. by R.Mohan, General Secretary, 61, Pallavan Nagar, 1st Cross Street, 1st Main Road, Thiruverkadu, Chennai 600 077.
... Petitioner Vs.
1.K.Phanindra Reddy, IAS, Additional Chief Secretary to Government, Tamil Nadu Government, Transport Department, Secretariat, Chennai 600 009.
2.Dr.Alby John Varghese, IAS, Managing Director, Metropolitan Transport Corporation (Chennai) Ltd., Pallavan Illam, Pallavan Salai, Chennai 600 002.
...
Respondents Prayer: Contempt Petition is filed under Section 11 of Contempt of Courts Act, to punish the respondents for willful disobedience of the order passed in W.P.No.10634 of 2021 dated 25.03.2024. Page No.1 of 4
For Petitioner : Mr.S.T.Varadarajalu For Respondents : Mrs.M.Jayanthi, AGP for R1 Mr.C.Gauthamaraj for R2
ORDER
This Contempt Petition has been filed to punish the respondents for willful disobedience of the order passed in W.P.No.10634 of 2021 dated 25.03.2024.
2. When the matter was taken up for hearing, the learned Standing Counsel for the second respondent submitted that the order passed by this Court has been complied and the proceedings in this regard has been produced before this Court.
3. In view of the above submission, this Contempt Petition is closed. If the petitioner has got any grievance, he is at liberty to challenge the order passed by the second respondent.
Index : Yes /No 27.11.2024 Internet : Yes/No Speaking / Non-speaking gsk To Page No.2 of 4
1.K.Phanindra Reddy, IAS, Additional Chief Secretary to Government, Tamil Nadu Government, Transport Department, Secretariat, Chennai 600 009.
2.Dr.Alby John Varghese, IAS, Managing Director, Metropolitan Transport Corporation (Chennai) Ltd., Pallavan Illam, Pallavan Salai, Chennai 600 002.
Page No.3 of 4
R.N.MANJULA , J.
gsk 27.11.2024 Page No.4 of 4